China Medical GatewayLoading your healthcare gateway…

Li Zhi Gang

Li Zhi Gang — Chief Physician — Thoracic Surgery — Shanghai Chest Hospital

Specialties

Surgical treatment of various thoracic diseases, including surgery for lung cancer, esophageal cancer, mediastinum, chest wall, trachea, and other thoracic procedures. Particularly skilled in: - Minimally invasive surgical treatment of lung cancer, and various complex open lung surgeries - Robotic minimally invasive esophageal surgery; conventional thoracoscopic treatment of esophageal cancer - Colonic and jejunal replacement for complex esophageal diseases, including chemical burns of the esophagus and repeated esophageal cancer surgery after gastrointestinal operations - Endoscopic resection of early esophageal tumors - Surgical treatment of high-level and cervical esophageal cancer - Salvage surgery for recurrent esophageal cancer after radical radiotherapy - Minimally invasive treatment of benign esophageal diseases, including giant hiatal hernia, gastroesophageal reflux, and achalasia - Tracheal surgery: particularly skilled in surgical treatment of high-level tracheal stenosis (including laryngotracheal stenosis), post-intubation tracheal stenosis, and various tracheoesophageal fistulas - Surgical treatment of large and recurrent chest wall tumors

Education

PhD in Cardiothoracic Surgery from the Second Military Medical University Undergraduate in Clinical Medicine from the Second Military Medical University

Professional Experience

Chief physician, doctoral supervisor, Doctor of Medicine. Thoracic Surgery Department, Shanghai Chest Hospital. Evarts A. Graham Fellow of the American Association for Thoracic Surgery (2011-2012). Shanghai 'Oriental Talent' Leading Talent, Shanghai Craftsman. In 2011, received the most important talent training program in the international thoracic surgery community—the Graham Fellow training opportunity of the American Association for Thoracic Surgery, offered to one person annually, where he received systematic scientific research and clinical training at the five most important thoracic surgery medical centers in North America. In 2014, appointed Deputy Director of the Thoracic Surgery Department at Shanghai Chest Hospital, and in 2015 concurrently served as Director of the Esophageal Surgery Department, successfully leading the team to build the largest center in China for the diagnosis and treatment of complex esophageal diseases, establishing a 'one-stop' clinical diagnosis and treatment platform for esophageal diseases—including robotic-assisted minimally invasive surgery, comprehensive diagnosis and treatment system for esophageal cancer combining radiotherapy, chemotherapy, and immunotherapy, as well as the original technology for magnetic ring anti-reflux treatment of benign gastroesophageal reflux disease. Published 63 SCI papers in high-level academic journals including Cancer Cell (2023), J Immunother Cancer (2022), Nat Commun (2021), Ann Surg (2021), JTCVS (2023), led several important clinical trials, and has been the principal investigator of 1 key research and development project of the Ministry of Science and Technology, 1 international key project of the National Natural Science Foundation, 3 general projects of the National Natural Science Foundation, and multiple municipal/university-level projects. Elected as an outstanding academic leader and leading talent of Shanghai.

Professional Roles

Vice President of the Thoracic Surgery Branch of Shanghai Medical Association, Head of the Esophagus Study Group · Deputy Head of the Esophagus Study Group of the Thoracic Surgery Branch of China Medical Doctor Association · Standing Member of the Intelligent Equipment Technology Branch of China Medical Equipment Association · Member of the Esophageal Cancer Committee of the Chinese Anti-Cancer Association (CACA) · Member of the Endoscopist Branch of China Medical Doctor Association · Member of the Esophagus Study Group of the Thoracic and Cardiovascular Surgery Branch of Chinese Medical Association · Member of the Esophageal Cancer Committee of the Chinese Society of Clinical Oncology (CSCO) · Deputy Director of the Multidisciplinary Branch for Gastroesophageal Reflux of China Medical Promotion Association · Head of the Esophagus Study Group of Chinese Digestive Surgery Elite Forum · Member of the American Association for Thoracic Surgery (AATS) · Member of the International Society for Diseases of the Esophagus (ISDE)

Return to Home